Russia’s Pharmaceutical Imports under Sanctions Period

Alexander Sergeevich Firanchuk
Additional contact information
Alexander Sergeevich Firanchuk: Th e Russian Presidential Academy of National Economy and Public Administration, Moscow, Russia

Russian Foreign Economic Journal, 2025, issue 09, 42-59

Abstract: The article analyzes the changes in pharmaceutical imports to Russia during 2018-2024, which account for about half of the country’s pharmaceutical consumption. Based on data from UN Comtrade, Eurostat, and GACC, a panel of 83 exporting countries was compiled, covering 96% of Russia’s pre-sanction imports. In 2022–2024, the share of imports in pharmaceutical consumption remained largely unchanged, with supplies from “unfriendly” countries continued to dominate. An empirical analysis using a gravity model estimated with PPML method confirms the resilience of imports from the “unfriendly” countries and indicates a decline in medicines alongside an increase in substances supplied from neutral countries.

Keywords: Russian imports; sanctions; imports of pharmaceuticals; import substitution (search for similar items in EconPapers)
JEL-codes: F10 (search for similar items in EconPapers)
Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
http://repec.vavt.ru/RePEc/alq/rufejo/rfej_2025_09_42-59.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:alq:rufejo:rfej_2025_09_42-59

DOI: 10.64545/2072-8042-2025-9-42-59

Access Statistics for this article

More articles in Russian Foreign Economic Journal from Russian Foreign Trade Academy Ministry of economic development of the Russian Federation Contact information at EDIRC.
Bibliographic data for series maintained by Irina Katolik ().